A New Challenger Emerges: Could Viridian's Eye Disease Drug Outshine Amgen's Blockbuster Tepezza?

AutoZone Gears Up for a Solid Quarter as Analysts See Strong Consumer Rebound

American Eagle Outfitters Soars: Analysts Boost Forecasts After Stellar Q4 Performance

MongoDB's Stellar Q3 Performance Sparks Widespread Analyst Optimism and Lofty New Price Targets

Shattuck Labs Takes Flight: Goldman Sachs' Bold 'Buy' Rating Ignites Biotech Stock

The Great American Shopping Spree: Unpacking Black Friday & Thanksgiving's Record-Breaking Kickoff

MongoDB's Monday Moves: Decoding the Day's Market Action

CrowdStrike's Big Moment: Top Analysts Raise Price Targets Ahead of Earnings

Behind the Buzz: Why This Analyst Sees Big Things for Costco's Latest Quarter, Boosting Price Targets

The Latest Buzz: Wall Street's Top Stock Calls Unpacked

The Gold Rush Continues: Why Institutional Investors Are Eyeing a Staggering $5,000 Price Tag

Finding Stability in Shifting Markets: Top Analysts Point to High-Yielding Defensive Stocks

Novo Nordisk's Alzheimer's Trial: A Minor Blip for a Pharma Giant

The Bear Trap? Goldman Sachs Flags Big-Name Stocks with Soaring Short Interest

Whispers of Strong Performance: Why Top Analysts Are Upping Their Game for Semtech's Q3 Earnings

Market Shifts: Key Analyst Upgrades Point to Renewed Optimism Across Sectors

Riding the Rails of Doubt and Opportunity: Unpacking Wall Street's Verdict on Norfolk Southern

The Hims & Hers Rollercoaster: What's Fueling This Telehealth Giant's Latest Surge?

Turning the Page: Twist Bioscience Narrows Losses, Eyes 2026 Profitability with Renewed Vigor

The Silicon Showdown: Picking a Winner Between AMD and Agilysys

The Under-the-Skin Revolution: How Boosters Are Redefining Modern Beauty Standards

The Shifting Sands of Wall Street: What Evercore ISI's PPG Reassessment Means

When the Cream Rises: Saputo's Stock Surge and the Investor's Dilemma

Touchstone Exploration: A Dip in the Daily Dance, But What Lies Beneath?

Rockwell Medical's Latest Quarter: A Closer Look Beyond the Numbers

The Golden Shifting Sands: What Analysts Are Whispering About Gold Fields Now

The Shifting Sands of Biotech: What Analysts Really Think of Bicycle Therapeutics

Wall Street Whispers: What Analysts Are Really Saying About Flowserve's Future

The Curious Case of ORIC Pharma: Why Wall Street Just Tipped Its Hand on a Potential Upside

Unraveling the Market: Tech Giants, Dating Dynasties, and the Hunt for Hidden Value

Wall Street's Eye on Procore: Is $91 the New Horizon for the Construction Tech Giant?

A Wave of Confidence: Palomar's Latest Earnings Surprise Sparks a Stock Market Rally

Cellectis Navigates the Biotech Tides with a Surprise Earnings Beat

Definitive Healthcare: A Glimpse Behind the Numbers — And What They Truly Mean for Investors

BILL's Bold Bet: When the Market Whispers Doubt, a Tech Player Delivers

Enbridge's Q3: A Bit of a Bump in the Road, But Dividends Still Flow

AstraZeneca's Quiet Triumph: A Deeper Dive into Q3's Surprising Win

The Pulse of Pharma: AstraZeneca's Latest Beat Resonates Through the Market

Evertec's Unexpected Ascent: Decoding a Stellar Q3 and What It Means for the Road Ahead